San Francisco、CAにおける前立腺がんの臨床試験

San Franciscoとその周辺地域（約30マイル以内）の拠点で、前立腺がんに関する45件の研究が参加者を募集しています。研究を開いて、参加資格と連絡方法を確認してください。

公式研究テキスト（英語）

ここで研究参加者を募集していますか？このページの上部に表示できます — 30日間 $99 →

Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial

被験者募集中第3相

Kaiser Permanente-San Francisco, San Francisco

18歳以上 · 男性 · 2026/10/02更新 · NCT06931340

Distance-Based Exercise to Preserve Function and Prevent Disability

被験者募集中

Kaiser Permanente-San Francisco, San Francisco

18歳以上 · 全性別 · 2026/10/02更新 · NCT07059884

Precision-Based Genomics in Prostate Cancer

被験者募集中観察研究

University of California San Francisco, San Francisco

18歳〜120歳 · 男性 · 2026/09/28更新 · NCT04706663

A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)

被験者募集中第3相

San Francisco VA Health Care System ( Site 0093), San Francisco

18歳以上 · 全性別 · 2026/09/25更新 · NCT06136650

A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer

被験者募集中第3相

University of California San Francisco, San Francisco

18歳以上 · 男性 · 2026/09/22更新 · NCT07213674

Sacral Neuromodulation for Male Overactive Bladder (MOAB)

被験者募集中

University of California San Francisco, San Francisco

18歳以上 · 男性 · 2026/09/14更新 · NCT06511141

Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer

被験者募集中第3相

Kaiser Permanente-San Francisco, San Francisco

18歳以上 · 男性 · 2026/09/10更新 · NCT05946213

Pembrolizumab Plus 177Lu-PSMA-617 in Patients With Castration Resistant Prostate Cancer

被験者募集中第2相

University of California, San Francisco, San Francisco

18歳以上 · 男性 · 2026/09/10更新 · NCT05766371

Prostate Active Surveillance Study

被験者募集中観察研究

Veterans Affairs San Francisco Health Care System, San Francisco
University of California, San Francisco, San Francisco

21歳以上 · 男性 · 2026/09/02更新 · NCT00756665

A Study of Tarlatamab for People With Prostate Cancer

被験者募集中第2相

University of California San Francisco, San Francisco

18歳以上 · 男性 · 2026/08/31更新 · NCT07111507

Comparison of 177Lu-PSMA-617 and 225Ac-PSMA-617

被験者募集中第1相

University of California, San Francisco, San Francisco

18歳以上 · 男性 · 2026/08/28更新 · NCT07054346

COMPASS Study for Metastatic Castration-resistant Prostate Cancer

被験者募集中観察研究

UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco

18歳以上 · 男性 · 2026/08/27更新 · NCT07050433

AZD2265 Compared With Standard of Care in PSMA-positive Metastatic Castration-resistant Prostate Cancer (VECTRA-01)

被験者募集中第3相

Research Site, San Francisco

18歳以上 · 男性 · 2026/08/26更新 · NCT07611110

Study of AMG 509 in Participants With Metastatic Castration-Resistant Prostate Cancer

被験者募集中第1相

University of California San Francisco, San Francisco

18歳以上 · 男性 · 2026/08/21更新 · NCT04221542

A Study of FG-3246 in Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC)

被験者募集中第2相

University of California San Francisco, San Francisco

18歳以上 · 男性 · 2026/08/17更新 · NCT06842498

FOG-001 in Locally Advanced or Metastatic Solid Tumors

被験者募集中第1/2相

University of California San Francisco, Helen Diller Family Comprehensive Cancer Center, San Francisco

18歳以上 · 全性別 · 2026/08/17更新 · NCT05919264

Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)

被験者募集中第1相

UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco

18歳〜100歳 · 男性 · 2026/08/13更新 · NCT05519449

Study of AZD9574 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid Malignancies

被験者募集中第1/2相

Research Site, San Francisco

18歳〜130歳 · 全性別 · 2026/08/12更新 · NCT05417594

A Study of DM002 in Patients With Advanced Solid Tumors

被験者募集中第1/2相

University of California San Francisco Cancer Center, San Francisco

18歳以上 · 全性別 · 2026/08/07更新 · NCT06751329

Evaluation of Neoadjuvant Xaluritamig in Localized Prostate Cancer

被験者募集中第1相

University of California San Francisco, San Francisco

18歳以上 · 男性 · 2026/07/31更新 · NCT06613100

Abemaciclib Before 177Lu-PSMA-617 for the Treatment of Metastatic Castrate Resistant Prostate Cancer

被験者募集中第1/2相

University of California, San Francisco, San Francisco

18歳以上 · 全性別 · 2026/07/24更新 · NCT05113537

PSMA PET Combined With MRI for the Detection of PCa

被験者募集中第3相健康なボランティア歓迎

University of California San Francisco, San Francisco

18歳以上 · 男性 · 2026/07/23更新 · NCT07052214

Imaging of Solid Tumors Using 18F-TRX

被験者募集中第1相

University of California, San Francisco, San Francisco

18歳以上 · 全性別 · 2026/07/23更新 · NCT06942104

A Clinical Study of KTX-2001 in Subjects With Metastatic Castration-Resistant Prostate Cancer (STRIKE-001)

被験者募集中第1相

University of California San Francisco, San Francisco

18歳以上 · 男性 · 2026/07/09更新 · NCT07103018

Social, Structural, and Lifestyle Drivers of Prostate Cancer Disparities

被験者募集中観察研究

University of California, San Francisco, San Francisco

18歳以上 · 男性 · 2026/07/08更新 · NCT07690579

Low PSMA SUV Boost (LPS-Boost): Intensified 177Lu-PSMA-617 Treatment for Patients With Metastatic Castrate-Resistant Prostate Cancer With Low PSMA Expressing Disease

被験者募集中第2相

University of California San Francisco, San Francisco

18歳以上 · 男性 · 2026/07/07更新 · NCT06526299

Study Evaluating the Safety, Tolerability, and Efficacy of Xaluritamig in Combination With Androgen Receptor Pathway Inhibitors in Participants With Metastatic Hormone-sensitive Prostate Cancer

被験者募集中第1相

University of California San Francisco, San Francisco

18歳以上 · 男性 · 2026/07/02更新 · NCT07140900

Neoadjuvant Atezolizumab-Based Combination Therapy in Men With Localized Prostate Cancer Prior to Radical Prostatectomy

被験者募集中第2相

University of California, San Francisco, San Francisco

18歳以上 · 男性 · 2026/06/04更新 · NCT03821246

177Lu-PSMA-617 With Liver Directed Therapy in Metastatic Castration Resistant Prostate Cancer

被験者募集中第1相

University of California, San Francisco, San Francisco

18歳以上 · 男性 · 2026/06/01更新 · NCT07145177

Hyperpolarized Pyruvate (13C) MR Imaging in Monitoring Patients With Prostate Cancer on Active Surveillance

被験者募集中第2相

University of California, San Francisco, San Francisco

18歳以上 · 男性 · 2026/05/18更新 · NCT03933670

Prostate Cancer Screening for People at Genetic Risk for Aggressive Disease, PATROL Study

被験者募集中観察研究健康なボランティア歓迎

University of California, San Francisco, San Francisco

40歳以上 · 男性 · 2026/05/15更新 · NCT04472338

Evaluation of Prostate Specific Membrane Antigen Positron Emission Tomography-Computed Tomography in Active Surveillance for Prostate CancEr

被験者募集中

UCSF, San Francisco

18歳以上 · 男性 · 2026/05/04更新 · NCT05948657

Pilot Study of (MR) Imaging With Pyruvate (13C) to Detect High Grade Prostate Cancer

被験者募集中早期第1相

University of California, San Francisco, San Francisco

18歳以上 · 男性 · 2026/04/30更新 · NCT02526368

Tumor Genomic Pre-test Counseling Tool for Black or African-American Men With Prostate Cancer

被験者募集中

University of California, San Francisco

18歳以上 · 男性 · 2026/04/16更新 · NCT06171139

Androgen Suppression Combined With Nodal Irradiation and Dose Escalated Prostate Treatment

被験者募集中第3相

Kaiser Permanente-San Francisco, San Francisco

18歳以上 · 男性 · 2026/04/14更新 · NCT06235697

Mechanisms of Resistance to PSMA Radioligand Therapy

被験者募集中観察研究

University of California, San Francisco, San Francisco

18歳以上 · 全性別 · 2026/03/18更新 · NCT05435495

64Cu-GRIP B in Patients With Advanced Malignancies

被験者募集中第1/2相

University of California, San Francisco, San Francisco

18歳以上 · 全性別 · 2026/03/17更新 · NCT05888532

Patient Decision-making About Precision Oncology in Veterans With Advanced Prostate Cancer

被験者募集中

San Francisco Veterans Affairs Medical Center, San Francisco

18歳以上 · 全性別 · 2026/03/09更新 · NCT05396872

Phase 1/2 Dose Finding, Safety and PK Study in Advanced Refractory Solid Tumors

被験者募集中第1/2相

UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco

18歳以上 · 全性別 · 2026/02/17更新 · NCT07145255

A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation

被験者募集中第1相

University of California San Francisco, San Francisco

18歳以上 · 全性別 · 2026/02/13更新 · NCT06778863

Magnetic Resonance (MR) Imaging With Hyperpolarized 13C-Pyruvate +/- 13C,15N-Urea in Patients With Prostate Cancer

被験者募集中第2相

University of California, San Francisco, San Francisco

18歳以上 · 男性 · 2026/01/07更新 · NCT06391034

Community-Based Health Coach for Access to Germline Genetic Testing Among African American Men With Prostate Cancer

被験者募集中

Zuckerberg San Francisco General Hospital, San Francisco
San Francisco Veterans Administration Medical Center, San Francisco
University of California San Francisco, San Francisco

18歳以上 · 男性 · 2025/12/31更新 · NCT04763980

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

被験者募集中観察研究

Massive Bio SYNERGY-AI site, San Francisco

全年齢 · 全性別 · 2025/10/28更新 · NCT03452774

Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer

被験者募集中第3相

Kaiser Permanente-San Francisco, San Francisco

18歳以上 · 男性 · 2025/09/11更新 · NCT03678025

ART-Pro: Clinical Trial Evaluating Biparametric MRI and Advanced, Quantitative Diffusion MRI for Detection of Prostate Cancer

被験者募集中観察研究

University of California, San Francisco, San Francisco

18歳以上 · 男性 · 2024/11/06更新 · NCT06579417

他の都市における前立腺がんの試験

San Franciscoにおける他の研究

ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。